Researchers discover how the brain ‘re-wires’ after disease
Trinity researchers are studying how the brain re-wires itself in neurological disease. The team is building treatments for today’s more […]
Melbourne researchers have published a breakthrough study that will accelerate new treatments for an often-fatal disease affecting premature babies in […] A first-of-its-kind study from the University of Roehampton has found that the use of telephone clinics improved adherence to a […] As the United States surpassed 200,000 coronavirus deaths recently, many are asking one simple question: When will it end? Politicians […] A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects […] Dilated cardiomyopathy (DCM) is a leading cause of heart failure, affecting 1 in 250 people. DCM is characterized by an […] ‘Social smokers’ are more than twice as likely to die of lung disease and more than eight times as likely […] Physicists at the University of Göttingen, together with pathologists and lung specialists at the Medical University of Hannover, have developed […] (HealthDay)—Lymphoma survivors are at substantial long-term risk for chronic kidney disease (CKD) development, according to a study published online July […] Results from a randomized clinical trial have shown that a potential new treatment can help control the immune response of […]disease
First treatment closer for fatal disease affecting premature babies
Telephone clinics can be effective in helping patients manage celiac disease during and post-COVID-19
Herd immunity could protect us from COVID-19—in theory. Infectious disease experts explain
A genetic variant that protects against Alzheimer’s disease promotes immune cell functions
Using genetics and personalized medicine to treat cardiovascular disease
‘Social smokers’ face disproportionate risk of death from lung disease and lung cancer
New insights into lung tissue in COVID-19 disease
Lymphoma survivors at risk for developing chronic kidney disease
New insights from first clinical trial of potential treatment for motor neurone disease